journal
MENU ▼
Read by QxMD icon Read
search

Blood Research

journal
https://www.readbyqxmd.com/read/29963532/retraction
#1
(no author information available yet)
[This retracts the article on p. 87 in vol. 53, PMID: 29662870.].
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963531/granulocytic-dysplasia-an-indicator-of-clonal-evolution-in-patients-with-chronic-myeloid-leukemia
#2
Sweta Rajpal, Ram V Nampoothiri, Sreejesh Sreedharanunni, Mayur Parihar, Pankaj Malhotra, Neelam Varma
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963530/acetate-moderately-attenuates-the-generation-of-neutrophil-extracellular-traps
#3
Ayako Ohbuchi, Mari Kono, Mariko Takenokuchi, Shion Imoto, Katsuyasu Saigo
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963529/primary-cns-lymphoma-latest-updates-and-a-10-year-monocenter-experience
#4
COMMENT
Emanuele Cencini, Alberto Fabbri, Luana Schiattone, Alfonso Cerase, Monica Bocchia
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963528/peripheral-neuropathy-associated-with-imatinib-therapy-for-chronic-myeloid-leukemia
#5
Simon Kavanagh, Vera Bril, Jeffrey H Lipton
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963527/long-term-control-of-refractory-follicular-lymphoma-after-treatment-of-secondary-acute-promyelocytic-leukemia-with-arsenic-trioxide-as-2-o-3-and-all-trans-retinoic-acid-atra
#6
Preetesh Jain, Sergej Konoplev, Ohad Benjamini, Jorge Romagura, Jan A Burger
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963526/microangiopathic-hemolytic-anemia-as-initial-presentation-of-recurrent-colon-cancer
#7
Joowon Park
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963525/evaluation-of-thrombocytopenia-in-the-hematology-clinic-a-case-series-from-a-large-tertiary-care-center
#8
Aishwarya Ravindran, Ronald S Go, Kaaren K Reichard, Ariela L Marshall
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963524/the-first-concurrent-diagnosis-of-acute-symptomatic-babesiosis-and-chronic-myeloid-leukemia-in-a-healthy-young-adult
#9
Yan Xie, Valeria Visconte, Lei Duan, Heesun J Rogers
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963523/synchronous-hairy-cell-leukemia-and-chronic-lymphocytic-leukemia-a-case-report-with-a-brief-review-of-literature
#10
Pulkit Rastogi, Preethi Jeyaraman, Man Updesh Sachdeva, Pankaj Malhotra, Jasmina Ahluwalia
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963522/the-incidence-of-atypical-patterns-of-bcr-abl1-rearrangement-and-molecular-cytogenetic-response-to-tyrosine-kinase-inhibitor-therapy-in-newly-diagnosed-cases-with-chronic-myeloid-leukemia-cml
#11
Željka Tkalčić Švabek, Marina Josipović, Ivana Horvat, Renata Zadro, Sanja Davidović-Mrsić
Background: To analyze the frequency of atypical fluorescence in situ hybridization signal patterns and estimate the complete cytogenetic response (CCyR) and major molecular response (MMR) during 12 months of tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia. Methods: The study included bone marrow and peripheral blood samples from 122 patients with newly diagnosed chronic myeloid leukemia. Detection of the breakpoint cluster region - Abelson fusion gene ( BCR-ABL1 ) was performed using fluorescence in situ hybridization with a dual-color dual-fusion translocation probe, and MMR analysis was performed using the real-time quantitative polymerase chain reaction method...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963521/allogeneic-hematopoietic-stem-cell-transplantation-in-congenital-hemoglobinopathies-with-myeloablative-conditioning-and-rabbit-anti-thymocyte-globulin
#12
Bo-Kyoung Park, Hyo-Sup Kim, Seongkoo Kim, Jae-Wook Lee, Young Shil Park, Pil-Sang Jang, Nack-Gyun Chung, Dae-Chul Jeong, Bin Cho
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for β-thalassemia major (TM) and sickle cell disease (SCD) in children. Graft-versus-host disease (GVHD) and treatment-related mortality (TRM) remain significant challenges to improving survival after HSCT. Here, we analyzed the outcome of TM and SCD patients, who received allogeneic HSCT with myeloablative conditioning at our institution. Methods: Twenty-two patients (15 TM, 7 SCD), with a median age of 9 years (range, 1...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963520/leukemia-propagating-cells-in-philadelphia-chromosome-positive-all-a-resistant-phenotype-with-an-adverse-prognosis
#13
Nadia El-Menshawy, Sherin M Abd-Aziz, Enas M Elkhamisy, Mohammed A Ebrahim
Background: Targeted therapy has revolutionized the management of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL); however, relapse still occurs because of the presence of quiescent stem cells, termed leukemia propagating cells (LPCs). This study aimed to assess the phenotypic diversity of LPCs in adult patients with Ph+ B-Acute ALL (B-ALL) and to assess its prognostic impact. Methods: Seventy adults with newly diagnosed Ph+ B-ALL were recruited at the Mansoura Oncology Center...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963519/clinical-characteristics-and-outcomes-of-thrombotic-microangiopathy-in-malaysia
#14
Yee Yee Yap, Jameela Sathar, Kian Boon Law, Putri Astina Binti Zulkurnain, Syed Carlo Edmund, Kian Meng Chang, Ross Baker
Background: Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13) outcome is unknown hence the survival analysis correlating with ADAMTS-13 activity is conducted in Malaysia. Methods: This was a retrospective epidemiological study involving all cases of TMA from 2012-2016. Results: We evaluated 243 patients with a median age of 34.2 years; 57.6% were female...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963518/effectiveness-of-darbepoetin-alfa-in-multiple-myeloma-patients-receiving-chemotherapy-including-novel-agents
#15
Sung-Eun Lee, Young-Woo Jeon, Jae-Ho Yoon, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Woo-Sung Min, Chang-Ki Min
Background: The aim of this study was to evaluate the effects of darbepoetin alfa (DA) on hemoglobin (Hb) concentration and the need for transfusions in multiple myeloma (MM) patients receiving chemotherapy with novel agents. Methods: Of 251 patients with MM who received DA therapy for at least 4 weeks, 142 who did not receive RBC transfusion during 4 weeks after DA initiation and started DA therapy at baseline Hb <10.0 g/dL were analyzed. Results: After 4 weeks of DA therapy, 80 (60...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963517/impact-of-rituximab-and-half-dose-chop-as-primary-therapy-for-untreated-symptomatic-waldenstr%C3%A3-m-macroglobulinemia-review-of-a-combined-regimen-of-rituximab-with-an-alkylating-agent
#16
Naohiro Sekiguchi, Airi Hamano, Tomoko Kitagawa, Yuya Kurihara, Kenichi Ito, Miwa Kurimoto, Kozo Watanabe, Kazuhiko Hirano, Satoshi Noto, Kazuaki Yamada, Naoki Takezako
Background: Waldenström Macroglobulinemia (WM) is a rare subtype of indolent B-cell lymphoma, and prospective randomized studies on WM are scarce. The R-CHOP therapy [rituximab (R), cyclophosphamide, hydroxy-doxorubicin, vincristine, and prednisone] is a popular and recommended regimen for primary therapy, prescribed by several treatment guidelines for WM. However, treatment with R-CHOP is accompanied by severe myelosuppression and high rates of peripheral neuropathy. Therefore, we retrospectively evaluated the efficacy and toxicity of half-dose CHOP combined with R as a primary therapy for WM...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963516/clinical-characteristics-and-treatment-courses-for-cytomegalovirus-associated-thrombocytopenia-in-immunocompetent-children-after-neonatal-period
#17
Min Ji Jin, Yunkyum Kim, Eun Mi Choi, Ye Jee Shim, Heung Sik Kim, Jin Kyung Suh, Ji Yoon Kim, Kun Soo Lee, Sun Young Park, Jae Min Lee, Jeong Ok Hah
Background: Cytomegalovirus (CMV) causes severe diseases in premature infants and immunocompromised hosts, and antiviral therapy is often required for disease control. However, the clinical manifestations and treatment courses for CMV-associated thrombocytopenia in immunocompetent children are unclear. Methods: Medical records of the children who suffered from thrombocytopenia, and showed positive CMV polymerase chain reaction and CMV-like symptoms were retrospectively analyzed at three university hospitals in Daegu from January 2000 to March 2017...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963515/busulfan-plus-melphalan-versus-high-dose-melphalan-as-conditioning-regimens-in-autologous-stem-cell-transplantation-for-newly-diagnosed-multiple-myeloma
#18
Ja Min Byun, Jayoun Lee, Sang-Jin Shin, Minjoo Kang, Sung-Soo Yoon, Youngil Koh
Background: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL) is also associated with favorable outcomes. We performed the current study to address the lack of comparative studies between the two conditioning regimens in Asian populations. Methods: Using the Korean National Health Insurance and Korean Health Insurance Review and Assessment Service databases, 1,304 patients newly diagnosed with MM undergoing ASCT between January 2010 and December 2014 were identified...
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963514/del-5q-myelodysplastic-syndrome-combined-with-pure-red-cell-aplasia
#19
Joowon Park
No abstract text is available yet for this article.
June 2018: Blood Research
https://www.readbyqxmd.com/read/29963513/splenic-marginal-zone-lymphoma-relapsing-as-miliary-lung-mottling-an-unusual-presentation
#20
Tanmoy Mandal, Anuj Verma, Vikas Talreja, Sangeetha Kamrajpuram Parthiban, Anant Gokarn, Hasmukh Jain, Bhausaheb Bagal, Sandeep Tandon, Manju Sengar, Tanuja Shet
No abstract text is available yet for this article.
June 2018: Blood Research
journal
journal
47644
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"